Portable Lab Solutions

Harnessing the Power of Mass Spectrometry & Machine Learning to Create Disruptive

ONE Breath at a Time

INSPECTIR SYSTEMS INC

Creators of the First Breath Device to Receive Any Level of FDA Authorization

FDA EUA GRANTED 4/1/2022 — EUA220006

READ MORE ABOUT US
TIME The Best Inventions 2022
Best Award THE BEST INVENTIONS OF 2022
FIDO Inspect IR - Bafômetro de drogas, identificação forense de drogas e orgânicos

Introducing FIDO - Forensic
Identification of Drugs and Organics

The United States is in the midst of a deadly fentanyl epidemic. It is storming our borders and arriving at our ports in overwhelming numbers. Current interdiction methods are costly and dangerous. InspectIR Systems introduces a solution to reduce exposure risks to first responders and canine search assets. This is FIDO.

READ MORE ABOUT FIDO

A Very Different Look at Medical Screening & Diagnostics

InspectIR's PNY-1000 system is a respiratory test that provides lab-caliber analytics in the field with over 90% sensitivity, delivering results in minutes instead of days.

The system requires no storage of biological material, reducing waste and cross-infection risks.

What makes us different:

  • Chemical lab in a box: we are analyzing breath via mass spectrometry.
  • InspectIR is the first company to produce a commercially available miniature mass spectrometer to analyze breath samples directly.
LEARN MORE ABOUT THE TECHNOLOGY
InspectIR PNY-1000 portable device
Tempo de teste: dispositivo PNY-1000, uso e teste respiratório

Total Estimated Time to Test: 3 Minutes

The COVID-19 pandemic created an unknown situation, and InspectIR Systems responded by initiating research to help, yielding outstanding results.

READ MORE ABOUT US
InspectIR PNY-1000 COVID Testing Demo
InspectIR PNY-1000 COVID Testing Demo

Leveraging Proven Science to Monitor Health & Wellness Around the World

COLLECT SAMPLE

Subject Exhales through their mouth into a tube connected to a test kit, much like blowing up a balloon.

CHEMISTRY

Chemistry in the subject's breath is captured on the patented Inspector systems device.

ANALYSIS

Patent issued measurement process runs, allowing identification & qualification of COVID 19 markers & spectrometry.

RESULTS

InspectIR systems device analyzes and displays results utilizing proprietary software.

The Numbers Never Lie

InspectIR is the only testing methodology that does not create cross-reactivity, which leads to pre-analytical error, based on adding a solvent.

11,000+ CLINICAL TRIAL SUBJECTS
99.3% SENSITIVITY
3 MINUTES - TIME FROM SAMPLE COLLECTION TO RESULTS
1 NUMBER OF BREATHALYZERS TO RECEIVE ANY LEVEL OF FDA AUTHORIZATION

In the Media

O que a imprensa diz sobre a InspectIR

Nossa equipe no Brasil

Membro 1

Cargo

Membro 2

Cargo

Membro 3

Cargo

Membro 4

Cargo

Nossa equipe nos EUA

Tim C Wing

Tim C Wing

Co-Founder CEO

John A. Redmond Jr.

John A. Redmond Jr.

Co-Founder President

Luke Keiser

Luke Keiser

VP Sales

Dr. Verbeck

Dr. Verbeck

Advisory Board Member

Contact InspectIR Systems, Inc.

Inspect IR is in rapid growth mode… interested in learning more? Complete the form below & a member of our team will be in touch shortly.